Top Markets
#1 Akedo Akedo +82.13%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.35%
#4 Cross Cross +45.57%
#5 Black Phoenix Black Phoenix +34.20%
#6 Velvet Velvet +32.22%
#7 Cap Cap +21.97%
#8 OVERTAKE OVERTAKE +20.36%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.80%
#10 QANplatform QANplatform +14.83%
Coin of the day
Akedo Akedo
설정
언어
한국어
통화
USD
테마
GABY Inc. GABY Inc.

GABY Inc.

GABY
주식 순위 #38694
GABY Inc., through its subsidiaries, is engaged in the manufacturing,... GABY Inc., through its subsidiaries, is engaged in the manufacturing, promotion, distribution, and retail sale of cannabis-related consumer packaged goods across the United States. The firm's offerings span a broad array of cannabis products, such as packaged flower, concentrated extracts, pre-rolled items, edibles, topical applications, tinctures, and other goods infused with or derived from cannabis or hemp. These cannabis products are marketed under the brand names Mankind, Kind Republic, Lulu's, 2Rise, and Dank Space. Established in 2003, the company was formerly known as Gabriella's Kitchen Inc. before rebranding as GABY Inc. in September 2019. GABY Inc. maintains its headquarters in Calgary, Canada.
주가
$0.00372038
마지막 동기화: 2023-08-11
시가총액
$849.73K
변동 (1일)
0.04%
변동 (1년)
0.00%
국가
CA
거래 GABY Inc. (GABY)

카테고리

Healthcare
GABY Inc. (GABY)의 P/B 비율
2026 기준 P/B 비율 TTM: 0
GABY Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0입니다. 2026년 말 기준 P/B 비율은 0였습니다.
GABY Inc.의 P/B 비율 기록 (2026 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.6634 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0941 -
US